Addressing  ||| S:0 E:11 ||| VBG
standards  ||| S:11 E:21 ||| NNS
of  ||| S:21 E:24 ||| IN
care  ||| S:24 E:29 ||| NN
in  ||| S:29 E:32 ||| IN
resource-limited  ||| S:32 E:49 ||| JJ
settings  ||| S:49 E:58 ||| NNS
:  ||| S:58 E:60 ||| :
The  ||| S:60 E:64 ||| DT
choice  ||| S:64 E:71 ||| NN
between  ||| S:71 E:79 ||| IN
best-known  ||| S:79 E:90 ||| JJS
standards  ||| S:90 E:100 ||| NNS
of  ||| S:100 E:103 ||| IN
care  ||| S:103 E:108 ||| NN
( ||| S:108 E:109 ||| -LRB-
SOC ||| S:109 E:112 ||| NNP
)  ||| S:112 E:114 ||| -RRB-
or  ||| S:114 E:117 ||| CC
best  ||| S:117 E:122 ||| RBS
available  ||| S:122 E:132 ||| JJ
standards  ||| S:132 E:142 ||| NNS
as  ||| S:142 E:145 ||| IN
the  ||| S:145 E:149 ||| DT
control  ||| S:149 E:157 ||| NN
arm  ||| S:157 E:161 ||| NN
in  ||| S:161 E:164 ||| IN
a  ||| S:164 E:166 ||| DT
clinical  ||| S:166 E:175 ||| JJ
trial  ||| S:175 E:181 ||| NN
is  ||| S:181 E:184 ||| VBZ
a  ||| S:184 E:186 ||| DT
fundamental  ||| S:186 E:198 ||| JJ
dilemma  ||| S:198 E:206 ||| NN
in  ||| S:206 E:209 ||| IN
clinical  ||| S:209 E:218 ||| JJ
research  ||| S:218 E:227 ||| NN
in  ||| S:227 E:230 ||| IN
resource-limited  ||| S:230 E:247 ||| JJ
settings  ||| S:247 E:256 ||| NNS
( ||| S:256 E:257 ||| -LRB-
RLS ||| S:257 E:260 ||| NNP
) ||| S:260 E:261 ||| -RRB-
.  ||| S:261 E:263 ||| .
When  ||| S:263 E:268 ||| WRB
the  ||| S:268 E:272 ||| DT
health  ||| S:272 E:279 ||| NN
system  ||| S:279 E:286 ||| NN
is  ||| S:286 E:289 ||| VBZ
delivering  ||| S:289 E:300 ||| VBG
less  ||| S:300 E:305 ||| JJR
than  ||| S:305 E:310 ||| IN
an  ||| S:310 E:313 ||| DT
optimal  ||| S:313 E:321 ||| JJ
level  ||| S:321 E:327 ||| NN
of  ||| S:327 E:330 ||| IN
care ||| S:330 E:334 ||| NN
,  ||| S:334 E:336 ||| ,
using  ||| S:336 E:342 ||| VBG
highest  ||| S:342 E:350 ||| JJS
standard  ||| S:350 E:359 ||| NN
of  ||| S:359 E:362 ||| IN
care  ||| S:362 E:367 ||| NN
in  ||| S:367 E:370 ||| IN
a  ||| S:370 E:372 ||| DT
clinical  ||| S:372 E:381 ||| JJ
trial  ||| S:381 E:387 ||| NN
may  ||| S:387 E:391 ||| MD
produce  ||| S:391 E:399 ||| VB
results  ||| S:399 E:407 ||| NNS
that  ||| S:407 E:412 ||| WDT
cannot  ||| S:412 E:419 ||| RB
be  ||| S:419 E:422 ||| VB
implemented  ||| S:422 E:434 ||| VBN
or  ||| S:434 E:437 ||| CC
sustained  ||| S:437 E:447 ||| VBD
locally ||| S:447 E:454 ||| RB
.  ||| S:454 E:456 ||| .
On  ||| S:456 E:459 ||| IN
the  ||| S:459 E:463 ||| DT
other  ||| S:463 E:469 ||| JJ
hand ||| S:469 E:473 ||| NN
,  ||| S:473 E:475 ||| ,
using  ||| S:475 E:481 ||| VBG
interventions  ||| S:481 E:495 ||| NNS
that  ||| S:495 E:500 ||| WDT
are  ||| S:500 E:504 ||| VBP
more  ||| S:504 E:509 ||| RBR
feasible  ||| S:509 E:518 ||| JJ
in  ||| S:518 E:521 ||| IN
the  ||| S:521 E:525 ||| DT
local  ||| S:525 E:531 ||| JJ
setting  ||| S:531 E:539 ||| NN
may  ||| S:539 E:543 ||| MD
involve  ||| S:543 E:551 ||| VB
suboptimal  ||| S:551 E:562 ||| JJ
care ||| S:562 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
and  ||| S:568 E:572 ||| CC
clinical  ||| S:572 E:581 ||| JJ
outcomes  ||| S:581 E:590 ||| NNS
may  ||| S:590 E:594 ||| MD
be  ||| S:594 E:597 ||| VB
affected ||| S:597 E:605 ||| VBN
.  ||| S:605 E:607 ||| .
The  ||| S:607 E:611 ||| DT
need  ||| S:611 E:616 ||| NN
for  ||| S:616 E:620 ||| IN
improved  ||| S:620 E:629 ||| JJ
standards  ||| S:629 E:639 ||| NNS
in  ||| S:639 E:642 ||| IN
health  ||| S:642 E:649 ||| NN
systems  ||| S:649 E:657 ||| NNS
in  ||| S:657 E:660 ||| IN
RLS ||| S:660 E:663 ||| NNP
,  ||| S:663 E:665 ||| ,
and  ||| S:665 E:669 ||| CC
the  ||| S:669 E:673 ||| DT
difficulty  ||| S:673 E:684 ||| NN
in  ||| S:684 E:687 ||| IN
securing  ||| S:687 E:696 ||| VBG
them ||| S:696 E:700 ||| PRP
,  ||| S:700 E:702 ||| ,
has  ||| S:702 E:706 ||| VBZ
led  ||| S:706 E:710 ||| VBN
many  ||| S:710 E:715 ||| JJ
researchers  ||| S:715 E:727 ||| NNS
advocate  ||| S:727 E:736 ||| VBP
for  ||| S:736 E:740 ||| IN
policy  ||| S:740 E:747 ||| NN
changes  ||| S:747 E:755 ||| NNS
at  ||| S:755 E:758 ||| IN
the  ||| S:758 E:762 ||| DT
national  ||| S:762 E:771 ||| JJ
or  ||| S:771 E:774 ||| CC
international  ||| S:774 E:788 ||| JJ
level  ||| S:788 E:794 ||| NN
to  ||| S:794 E:797 ||| TO
improve  ||| S:797 E:805 ||| VB
clinical  ||| S:805 E:814 ||| JJ
care  ||| S:814 E:819 ||| NN
more  ||| S:819 E:824 ||| RBR
systemically ||| S:824 E:836 ||| JJ
.  ||| S:836 E:838 ||| .
SOC  ||| S:838 E:842 ||| NNP
decisions  ||| S:842 E:852 ||| NNS
in  ||| S:852 E:855 ||| IN
a  ||| S:855 E:857 ||| DT
clinical  ||| S:857 E:866 ||| JJ
trial  ||| S:866 E:872 ||| NN
affect  ||| S:872 E:879 ||| VB
the  ||| S:879 E:883 ||| DT
level  ||| S:883 E:889 ||| NN
of  ||| S:889 E:892 ||| IN
benefit  ||| S:892 E:900 ||| NN
provided  ||| S:900 E:909 ||| VBD
to  ||| S:909 E:912 ||| TO
study  ||| S:912 E:918 ||| VB
participants  ||| S:918 E:931 ||| NNS
and  ||| S:931 E:935 ||| CC
the  ||| S:935 E:939 ||| DT
policy  ||| S:939 E:946 ||| NN
implications  ||| S:946 E:959 ||| NNS
of  ||| S:959 E:962 ||| IN
the  ||| S:962 E:966 ||| DT
trial  ||| S:966 E:972 ||| NN
findings ||| S:972 E:980 ||| NNS
.  ||| S:980 E:982 ||| .
SOC  ||| S:982 E:986 ||| NNP
choices  ||| S:986 E:994 ||| NNS
should  ||| S:994 E:1001 ||| MD
provide  ||| S:1001 E:1009 ||| VB
high-quality  ||| S:1009 E:1022 ||| JJ
care  ||| S:1022 E:1027 ||| NN
to  ||| S:1027 E:1030 ||| TO
help  ||| S:1030 E:1035 ||| VB
advance  ||| S:1035 E:1043 ||| VB
the  ||| S:1043 E:1047 ||| DT
health  ||| S:1047 E:1054 ||| NN
care  ||| S:1054 E:1059 ||| NN
system  ||| S:1059 E:1066 ||| NN
in  ||| S:1066 E:1069 ||| IN
host  ||| S:1069 E:1074 ||| NN
countries  ||| S:1074 E:1084 ||| NNS
participating  ||| S:1084 E:1098 ||| VBG
in  ||| S:1098 E:1101 ||| IN
the  ||| S:1101 E:1105 ||| DT
trial ||| S:1105 E:1110 ||| NN
,  ||| S:1110 E:1112 ||| ,
but  ||| S:1112 E:1116 ||| CC
balancing  ||| S:1116 E:1126 ||| VBG
the  ||| S:1126 E:1130 ||| DT
scientific  ||| S:1130 E:1141 ||| JJ
and  ||| S:1141 E:1145 ||| CC
ethical  ||| S:1145 E:1153 ||| JJ
objectives  ||| S:1153 E:1164 ||| NNS
of  ||| S:1164 E:1167 ||| IN
SOC  ||| S:1167 E:1171 ||| NNP
choices  ||| S:1171 E:1179 ||| NNS
is  ||| S:1179 E:1182 ||| VBZ
difficult ||| S:1182 E:1191 ||| JJ
,  ||| S:1191 E:1193 ||| ,
and  ||| S:1193 E:1197 ||| CC
there  ||| S:1197 E:1203 ||| EX
is  ||| S:1203 E:1206 ||| VBZ
no  ||| S:1206 E:1209 ||| DT
single  ||| S:1209 E:1216 ||| JJ
formula  ||| S:1216 E:1224 ||| NN
for  ||| S:1224 E:1228 ||| IN
selecting  ||| S:1228 E:1238 ||| VBG
the  ||| S:1238 E:1242 ||| DT
appropriate  ||| S:1242 E:1254 ||| JJ
SOC ||| S:1254 E:1257 ||| NNP
.  ||| S:1257 E:1259 ||| .
Despite  ||| S:1259 E:1267 ||| IN
the  ||| S:1267 E:1271 ||| DT
challenges ||| S:1271 E:1281 ||| NNS
,  ||| S:1281 E:1283 ||| ,
well-designed  ||| S:1283 E:1297 ||| JJ
and  ||| S:1297 E:1301 ||| CC
conducted  ||| S:1301 E:1311 ||| VBN
clinical  ||| S:1311 E:1320 ||| JJ
trials  ||| S:1320 E:1327 ||| NNS
can  ||| S:1327 E:1331 ||| MD
and  ||| S:1331 E:1335 ||| CC
should  ||| S:1335 E:1342 ||| MD
make  ||| S:1342 E:1347 ||| VB
significant  ||| S:1347 E:1359 ||| JJ
contributions  ||| S:1359 E:1373 ||| NNS
to  ||| S:1373 E:1376 ||| TO
health  ||| S:1376 E:1383 ||| NN
systems  ||| S:1383 E:1391 ||| NNS
in  ||| S:1391 E:1394 ||| IN
RLS ||| S:1394 E:1397 ||| NNP
.  ||| S:1397 E:1399 ||| .
